Switch View
© BusinessWire
24.09.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces New Employment Inducement Grants
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 9,750 shares of the Com...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Incyte (Nasdaq:INCY) announced today equity inducement awards grants to David H. Gardner, the Company’s new Executive Vice President, Chief Strategy Officer, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awards were approved by the compensation committee of the Company’s Board of Directors as an inducement material to the new...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare, Inc. 3rd Quarter 2025 Earnings Conference Call
News Preview
HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What:
HCA Healthcare, Inc. 3Q 2025 Earnings Call
When:
Friday, October 24, 2025 at 9:00 AM Central (10:00 AM Eastern)
How:
Live Audio over the Internet:
https://investor.hcahealthcare.com/events-and-presentations/default.aspx...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
24.09.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced the grant of inducement awards of options to purchase a collective total of up to 65,750 shares of common stock. Awards were made to eight new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
24.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Proposed Public Offering
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it has commenced an underwritten public offering of its common stock and, in lieu of common stock to certa...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, announced positive clinical data today from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 Phase 1 single ascending dose (...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Summary Notice of Proposed Settlement of Derivative Actions
News Preview
Owlet, Inc. (NYSE: OWLT) has released the following notice:
IN THE UNITED STATES DISTRICT COURT
FOR THE CENTRAL DISTRICT OF CALIFORNIA
IN RE OWLET, INC. SHAREHOLDER DERIVATIVE LITIGATION
Lead Case No.
2:24-cv-07258-FLA-PVC
This Document Relates to:
ALL ACTIONS.
NOTICE OF PROPOSED DERIVATIVE SETTLEME...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Announces Proposed Offering of $110.0 Million of Convertible Senior Notes
News Preview
KalVista Pharmaceuticals, Inc. (“KalVista”) (NASDAQ: KALV) announced today that it intends to offer, subject to market conditions and other factors, $110.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare announces cash dividend for third quarter of 2025
News Preview
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14, 2025 to all shareholders of record as of October 24, 2025.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US7402944000
Precision Optics Corp, Inc.
POCI
LISTED
NASDAQ
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025
News Preview
GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and fiscal year...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between D...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
News Preview
At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1.73m2 ( p<0.0001)Imlifidase was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission of a...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
24.09.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law Firm
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Kuehn Law Encourages Investors of Sarepta Therapeutics, Inc. to Contact Law Firm
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure Announces $200 Million Proposed Public Offering
News Preview
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $200 million underwritten public offering of its ordinary shares and, in lieu of ordinary shares to certai...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
News Preview
At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1.73m2 ( p<0.0001)Imlifidase was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission of a...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
News Preview
GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to its leadership combating the opioid crisis through a multi-faceted approach focused on awareness, education and...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US28617K1016
Eledon Pharmaceuticals, Inc.
ELDN
LISTED
NASDAQ
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
News Preview
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Inc. to Present at the MicroCap Rodeo Conference
News Preview
Thursday, September 25, 2025 in New York City Thursday, September 25, 2025 in New York City...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
News Preview
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Placement to Sanofi...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
News Preview
NEW HAVEN, Conn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ: IVVD) today announced the appointment of Paul B. Bolno, M.D., to its Board of Directors and as a member of the Compensation Committee. Dr. Bolno is the President and CEO of Wave Life Sciences, a clinical-stage biotechnology company, and has served in those roles since 201...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
News Preview
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Deadline Alert: Cytokinetics, Incorporated (CYTK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming November 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusi...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Jasper Therapeutics, Inc. (JSPR) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”). Jasper investors have until November 18, 2025 to file a lead plaintiff m...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.09.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
News Preview
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK populationThe facility marks a cornerstone of Moderna's ten-year strategic partnership with the UK Government, designed to strengthen health resilience and drive economic growth CAM...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Jasper Therapeutics, Inc. (JSPR) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”). Jasper investors have until November 18, 2025 to file a lead plaintiff...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Rosen Law Firm Urges Cytokinetics, Inc. (NASDAQ: CYTK) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025. Cytokinetics describes itself as a “biopharmaceutical company focused on discovering, developing, and commercializing first-in-c...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US00404A1097
Acadia Healthcare Company Inc
ACHC
LISTED
NASDAQ
Acadia Healthcare Issues Statement Highlighting Commitment to Value Creation
News Preview
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today issued the following statement:
Our Board of Directors and management team are steadfast in our commitment to enhancing long-term shareholder value. We regularly communicate with our shareholders regarding our value creation plan and welcome constructive input as we move forward.
At Acadia,...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Semler Scientific To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rig...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LFMD
News Preview
The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of LFMD during the class p...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
News Preview
Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price LOS ANGELES, CA / ACCESS Newswire / September 24, 2025 / Lunai Bioworks, Inc. (Nasdaq:RENB) ("Lunai Bioworks" or the "Company"), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that the Company's B...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi &...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CYTK To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Savara To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Faruqi & Fa...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Fa...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SMLR
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Semler Scientific, Inc. (“Semler” or “the Company”) (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of SMLR during...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LNTH To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lantheus To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruq...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: FR0000032526
Guerbet SA
GBT
LISTED
EURONEXT
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France
News Preview
H1 2025 results...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US92337F1075
Veracyte Inc
VCYT
LISTED
NASDAQ
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025
News Preview
Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced today that the first prospective validation data for a molecular signature to predict hormone therapy benefit in men with recurrent prostate cancer will be presented at ASTRO 2025, the annual meeting of the American Society for Radiation Oncology. The findings were der...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, October 22, 2025. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 23, 2025 at...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
News Preview
Press release – No. 14 / 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials
News Preview
SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, today announced a strategic partnership with CellCarta, a globally recognized provider of CRO laboratory services for pharmaceutical research and development. Under the pa...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott Hosts Conference Call for Third-Quarter Earnings
News Preview
ABBOTT PARK, Ill., Sept. 24, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor R...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US4131971040
Harmony Biosciences Holdings Inc
HRMY
LISTED
NASDAQ
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
News Preview
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ZYN002 in Fragile X syndrome (FXS). The RECONNECT Study did not meet the primary endpoint of improvement in social avoidance primarily due to a higher than expected placebo response rate.
Kuma...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that it has filed a definitive proxy statement and GREEN proxy card with the U.S. Securities and Exchange Commission (the “SEC”)...
Themefolio
Profiler
Peergroup
© Newsfile
24.09.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
News Preview
The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Acclaim® Fully Implanted Cochlear Implant OpportunitySix-month follow-up visits are now underway and will continue over the next two monthsWhite Bear Lake, Minnesota--(Newsfile Corp. - September 24, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Earns Spot on Forbes® First-Ever Ranking of Top U.S. Company Cultures America's Best Employers for Company Culture™
News Preview
Centene ranked among top 20 in U.S. insurance sector
ST. LOUIS, Sept. 24, 2025 /PRNewswire/ -- Centene Corporation ("Centene") [NYSE: CNC], a leading healthcare enterprise committed to helping people live healthier lives, has been named to the inaugural 2025 Forbes® America's Best Employers for Company Culture™ list. Ranking among the top third...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US92854B1098
Vivani Medical, Inc.
VANI
LISTED
NASDAQ
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025
News Preview
ALAMEDA, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that it will present at the Emerging Growth Conference 86 on September 25, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment
News Preview
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US5019761049
Kyverna Therapeutics, Inc.
KYTX
LISTED
NASDAQ
Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS
News Preview
KYV-101 IIT data demonstrate promising clinical activity, including robust CAR T penetration into the central nervous system (CNS) and improved expanded disability status scale scores (EDSS)...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: CA74040N1069
Predictmedix AI Inc
PMED
LISTED
CSE
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader
News Preview
Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, today outlined a strategic plan to evolve from a single-product health-screening company into a diversified, AI-driven health-technology enterprise with three complementary growth platforms....
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US0042251084
ACADIA Pharmaceuticals Inc
ACAD
LISTED
NASDAQ
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint
News Preview
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients with hyperphagia in Prader-Willi syndrome (PWS). Intranasal carbetocin did not demonstrate a statistically significant improvement over placebo on the study...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general and special meeting of shareholders (the “Meeting”) to September 26, 2025 at 9:00 AM ET. The Meeting will be held later the same day, at 1:00 PM...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
HARMONi-6, Featuring Ivonescimab Combined with Chemotherapy vs. Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in China, to be Showcased in Presidential Symposium at ESMO 2025
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data from the Phase III HARMONi-6 trial, conducted in China and sponsored by our partner, Akeso, Inc. (HKEX Code: 9926.HK), featuring the novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be featured as part of the P...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US09073M1045
Bio-Techne Corp
TECH
LISTED
NASDAQ
Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
News Preview
Company advances transition to renewable electricity and sets a pathway to science-based emissions reductions
MINNEAPOLIS, Sept. 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today released its 2025 Corporate Sustainability Report, underscoring the compa...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US6707031075
Nuvalent Inc
NUVL
LISTED
NASDAQ
Nuvalent to Participate in the UBS 2025 Virtual Oncology Day
News Preview
CAMBRIDGE, Mass., Sept. 24, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participa...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US5526411021
MAIA Biotechnology Inc
MAIA
LISTED
XASE
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
News Preview
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell lung cancer (NSCLC)...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US01625V1044
Alignment Healthcare Inc
ALHC
LISTED
NASDAQ
Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health
News Preview
New Alignment Health study shows nearly 2 in 5 seniors who experience loneliness say it’s impacting their health, 1 in 4 who have medical debt owe debt equal to 4+ months of living expenses New Alignment Health study shows nearly 2 in 5 seniors who experience loneliness say it’s impacting their health, 1 in 4 who have medical debt owe debt equal to...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
